Bio-Connect
WB analysis of rat spleen tissue lysate using GTX85027 URP2 antibody. Working concentration : (A) 1 and (B) 2 microg/ml
WB analysis of rat spleen tissue lysate using GTX85027 URP2 antibody. Working concentration : (A) 1 and (B) 2 microg/ml
WB analysis of rat spleen tissue lysate using GTX85027 URP2 antibody. Working concentration : (A) 1 and (B) 2 microg/ml

URP2 antibody

GTX85027
GeneTex
TargetFERMT3
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    URP2 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1 - 2 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Concentration
    1 mg/ml
  • Formulation
    Liquid
  • Gene ID83706
  • Target name
    FERMT3
  • Target description
    FERM domain containing kindlin 3
  • Target synonyms
    fermitin family homolog 3; fermitin family member 3; KIND3; kindlin 3; MIG-2; MIG2B; MIG2-like protein; UNC-112 related protein 2; UNC112C; unc-112-related protein 2; URP2; URP2SF
  • Protein IDQ86UX7
  • Protein Name
    Fermitin family homolog 3
  • Scientific Description
    The three KINDLINs are a novel family of focal adhesion proteins, localizing to integrin adhesion sites. The KINDLIN proteins are composed of a centrally located FERM domain interrupted by a pleckstrin homology (PH) domain. KINDLIN1 and KINDLIN2 have been shown to play an essential role in integrin-mediated adhesion and spreading. In contrast to the widely expressed KINDLIN1 and KINDLIN2, KINDLIN3 is restricted to hematopoietic cells and is particularly abundant in megakaryocytes and platelets. Several reports describe a transcriptional misregulation of KINDLINs in various types of cancer. A recent study demonstrates that KINDLIN3 is essential for platelet integrin activation and subsequent integrin outside-in signaling, suggesting it may serve as a potential target for the design of therapeutics aimed at specifically disrupting integrin activation in platelets and leukocytes.
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203